Famotidine (H2 Receptor Antagonist)

Описание к видео Famotidine (H2 Receptor Antagonist)

Please read and agree to the disclaimer before watching this video.
. More lectures on DrBeen.com

Donate to support my work:
https://paypal.me/mobeensyed?locale.x...

Famotidine, sold under the brand name Pepcid among others, is a medication that decreases stomach acid production.[2] It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome.[2] It is taken by mouth or by injection into a vein.[2] It begins working within an hour.[2]
Common side effects include headache, intestinal upset, and dizziness.[2] Serious side effects may include pneumonia and seizures.[2][3] Use in pregnancy appears safe but has not been well studied while use during breastfeeding is not recommended.[4] It is a histamine H2 receptor antagonist.[2]


Famotidine
https://en.wikipedia.org/wiki/Famotidine


Gastrin
https://en.wikipedia.org/wiki/Gastrin


Enterochromoaffin-like cells
https://en.wikipedia.org/wiki/Enteroc... ...

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

Комментарии

Информация по комментариям в разработке